The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection
Phase 2
Completed
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Parexel
- Target Recruit Count
- 225
- Registration Number
- NCT00002347
- Locations
- 🇺🇸
PAREXEL Intl Corp / InterCo Collaboration Ctr, Waltham, Massachusetts, United States
© Copyright 2024. All Rights Reserved by MedPath